EXACT Sciences Corp. (EXAS)

71.38
NASDAQ : Health Technology
Prev Close 68.87
Day Low/High 67.62 / 71.99
52 Wk Low/High 37.36 / 81.22
Avg Volume 2.09M
Exchange NASDAQ
Shares Outstanding 122.90M
Market Cap 8.46B
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Exact Sciences Stock: Buy at What Level?

Exact Sciences Stock: Buy at What Level?

Our strategy on EXAS shares after the company's latest earnings.

Costco, Tellurian, Exact Sciences: 'Mad Money' Lightning Round

Costco, Tellurian, Exact Sciences: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Costco, Tellurian, Exact Sciences, XPO Logistics, Align Technology and more.

Don't Write Off FANG: Cramer's 'Mad Money' Recap (Wednesday 10/31/18)

Don't Write Off FANG: Cramer's 'Mad Money' Recap (Wednesday 10/31/18)

Jim Cramer says investors need to remember how terrific these companies are, and why they can't be written off.

Cologuard® Revenue Increased 63 Percent To $118 Million, And Cologuard Test Volume Grew 49 Percent To 241,000 During Third Quarter

Cologuard® Revenue Increased 63 Percent To $118 Million, And Cologuard Test Volume Grew 49 Percent To 241,000 During Third Quarter

- Demand accelerated from healthcare providers as more than 11,000 ordered their initial Cologuard test during the third quarter, and nearly 132,000 have ordered since the test was launched

Raytheon, Northrop Grumman, Zuora: 'Mad Money' Lightning Round

Raytheon, Northrop Grumman, Zuora: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Raytheon, Northrop Grumman, Zuora, Exact Sciences.

Apple's Trillion-Dollar Market Cap: Cramer's 'Mad Money' Recap (Thur 8/2/18)

Apple's Trillion-Dollar Market Cap: Cramer's 'Mad Money' Recap (Thur 8/2/18)

This trillion-dollar level is so meaningful, Jim Cramer says, because Apple may be the first company to get here, but it won't be the last. Get ready.

Exact Sciences Strengthens Pipeline Capabilities With Acquisition Of Biomatrica, A Leading Provider Of Biological Sample Preservation Technology

Exact Sciences Strengthens Pipeline Capabilities With Acquisition Of Biomatrica, A Leading Provider Of Biological Sample Preservation Technology

Technology Promotes High-Quality Results from Liquid Biopsy Cancer Tests

Exact Sciences Schedules Third-quarter 2018 Earnings Call

Exact Sciences Schedules Third-quarter 2018 Earnings Call

MADISON, Wis., Oct.

EXACT Sciences Corp. Larger Than S&P 500 Component Qorvo

EXACT Sciences Corp. Larger Than S&P 500 Component Qorvo

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Qorvo Inc , according to The Online Investor.

Exact Sciences To Participate In September Investor Conferences

Exact Sciences To Participate In September Investor Conferences

MADISON, Wis., Aug.

Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer

Zoetis Could Pull Back in the Short Run, but We Have Higher Price Targets Longer

ZTS discovers, develops, manufactures, and markets veterinary vaccines and medicines.

Exact Sciences And Pfizer Enter Into U.S. Promotion Agreement For Cologuard®

Exact Sciences And Pfizer Enter Into U.S. Promotion Agreement For Cologuard®

Collaboration is expected to drive Cologuard adoption through expanded sales and marketing efforts

Green Bay Packers And Cologuard Launch "Crossing The 50" Colon Cancer Awareness Campaign

Green Bay Packers And Cologuard Launch "Crossing The 50" Colon Cancer Awareness Campaign

Fans taking screening pledge can be entered to win luxury box tickets

Tom Lehman Joins Forces With Fight Colorectal Cancer To Raise Awareness Of Nation's Second-Leading Cause Of Cancer Deaths

Tom Lehman Joins Forces With Fight Colorectal Cancer To Raise Awareness Of Nation's Second-Leading Cause Of Cancer Deaths

PGA TOUR Professional and Colon Cancer Survivor to Serve as Brand Ambassador for Fight CRC and Participate in Year-Long Public Service Announcement Campaign

Cologuard® Revenue Increased 78 Percent To $103 Million During Second Quarter

Cologuard® Revenue Increased 78 Percent To $103 Million During Second Quarter

- More than 10,000 healthcare providers ordered their initial Cologuard test during the second quarter, and nearly 121,000 have ordered since the test was launched

3 'Strong Buy' Healthcare Stocks Poised to Surge

3 'Strong Buy' Healthcare Stocks Poised to Surge

Here are the top healthcare bets ticking all the boxes for analysts.

Exact Sciences To Host Annual Meeting, Second-quarter 2018 Results Webcasts And Calls

Exact Sciences To Host Annual Meeting, Second-quarter 2018 Results Webcasts And Calls

MADISON, Wis., July 9, 2018 /PRNewswire/ -- Exact Sciences Corp.

Nurse Practitioners Are Critical Source Of Colorectal Cancer Screening Information For Patients, Survey Shows

Nurse Practitioners Are Critical Source Of Colorectal Cancer Screening Information For Patients, Survey Shows

SNAPP Survey Reveals Opportunity for NPs to Help Improve Screening Rates

Cologuard Challenge Expands To AmFam Championship Urging PGA TOUR Champions Fans To Get Screened For Colon Cancer

Cologuard Challenge Expands To AmFam Championship Urging PGA TOUR Champions Fans To Get Screened For Colon Cancer

Fans Signing Pledge will be Entered to Win VIP Experience

Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel To Accurately Diagnose Hepatocellular Carcinoma

Exact Sciences, Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel To Accurately Diagnose Hepatocellular Carcinoma

Data Presented at Digestive Disease Week Show Panel of Six Biomarkers is 95 Percent Sensitive for Most Common Type of Liver Cancer

Exact Sciences To Participate In June Investor Conferences

Exact Sciences To Participate In June Investor Conferences

MADISON, Wis., June 1, 2018 /PRNewswire/ -- Exact Sciences Corp.

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody Likes Tariffs: Cramer's 'Mad Money' Recap (Thursday 3/1/18)

Nobody likes tariffs, says Jim Cramer. But Trump said he'd do it. Even so, trade and tariff fears have hit Wall Street -- and investors -- hard.

Notable Friday Option Activity: EXAS, GTLS, CARB

Notable Friday Option Activity: EXAS, GTLS, CARB

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in EXACT Sciences Corp. , where a total volume of 12,345 contracts has been traded thus far today, a contract volume which is representative of approximately 1.2 million underlying shares (given that every 1 contract represents 100 underlying shares).

EXACT Sciences Corp. Larger Than S&P 500 Component Tripadvisor

EXACT Sciences Corp. Larger Than S&P 500 Component Tripadvisor

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Tripadvisor Inc , according to The Online Investor.

EXACT Sciences: Wait For a Better Buying Opportunity

EXACT Sciences: Wait For a Better Buying Opportunity

The stock still looks vulnerable to further declines from a technical perspective.

Exact Sciences: Cramer's Top Takeaways

Exact Sciences: Cramer's Top Takeaways

Kevin Conroy, chairman and CEO of Exact Sciences, tells Jim Cramer about his company's expansion plans for cancer screening tests.

TheStreet Quant Rating: C- (Hold)